Carotid artery stiffness in patients with end-stage renal disease: No effect of long-term homocysteine-lowering therapy

Clinical Nephrology

Volumn 53, Issue 1, 2000, Pages 33-41

  Van Guldener, C ^a,b   Lambert, J ^a   Ter Wee, P M ^a   Donker, A J M ^a   Stehouwer, C D A ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Arterial distensibility; Cardiovascular risk factors; Carotid artery stiffness; End stage renal disease; Folic acid; Homocysteine; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETAINE; CHOLESTEROL; CYANOCOBALAMIN; ENDOTHELIN; FOLIC ACID; HOMOCYSTEINE; VON WILLEBRAND FACTOR;

ADULT; AGE; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE REGULATION; CAROTID ARTERY DISEASE; CLINICAL TRIAL; COMMON CAROTID ARTERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEMODIALYSIS; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PERITONEAL DIALYSIS; RANDOMIZED CONTROLLED TRIAL; SMOKING;

AGE FACTORS; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD PRESSURE; BRACHIAL ARTERY; CAROTID ARTERY, COMMON; COMPLIANCE; ENDOTHELINS; HOMOCYSTEINE; HUMANS; KIDNEY FAILURE, CHRONIC; PYRIDOXINE; REGRESSION ANALYSIS; RENAL DIALYSIS; VASODILATION; VITAMIN B 12; VON WILLEBRAND FACTOR;

EID: 0033985366     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Barenbrock M, Spieker C, Laske V et al 1994 Studies of the vessel wall properties in hemodialysis patients. Kidney Int 45: 1397-1400
2. Becker BN, Himmelfarb J, Henrich WL, Hakim RM 1997 Reassessing the cardiac risk profile in chronic hemodialysis patients: A hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J Am Soc Nephrol 8: 475-486
3. Benetos A, Safar M, Rudnichi A et al 1997 Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 30: 1410-1415
4. 6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. J Vasc Surg 20: 933-940
5. Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM 1998 Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 12: 570-574
6. Blacher J, Demuth K, Guerin AP, Safar ME, Moatti N, London GM 1998 Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 18: 535-541
7. Fiorina P, Lanfredini M, Montanari A et al 1998 Plasma homocysteine and folate are related to arterial blood pressure in type 2 diabetes mellitus. Am J Hypertens 11: 1100-1107
8. Guldener van C, Lambert J, Janssen MJFM, Donker AJM, Stehouwer CDA 1997 Endothelium-dependent vasodilatation and distensibility of large arteries in chronic hemodialysis patients. Nephrol Dial Transplant 12 (Suppl 2): 14-18
9. Guldener van C, Janssen MJFM, Lambert J, Steyn M, Donker AJM, Stehouwer CDA 1998 Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients. Nephrol Dial Transplant 13: 1782-1786
10. Guldener van C, Janssen MJFM, Lambert J et al 1998 No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in hemodialysis patients. Nephrol Dial Transplant 13: 106-112
11. Guldener van C, Janssen MJFM, Lambert J, ter Wee PM, Donker AJM, Stehower CDA 1998 Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: No change in endothelial function after long-term therapy. Perit Dial Int 18: 282-289
12. Hirai T, Sasayama S, Kawasaki T, Yagi S 1989 Stiffness of systemic arteries in patients with myocardial infarction: A noninvasive method to predict severity of coronary atherosclerosis. Circulation 80: 78-86
13. Ibels LS, Alfrey AC, Huffer WE, Craswell PW, Anderson JT, Weil R 1979 Arterial calcification and pathology in uremic patients undergoing dialysis. Am J Med 66: 790-796
14. Kool MJF, van Merode T, Reneman RS, Hoeks APG, Struijker Boudier HAJ, van Bortel LMAB 1994 Evaluation of reproducibility of a vessel wall movement detector system for assessment of large artery properties. Cardiovasc Res 28: 610-614
15. Kool MJ, Lambert J, Stehouwer CDA, Hoeks AP, Struijker Boudier HA, van Bortel LM 1995 Vessel wall properties of large arteries in uncomplicated IDDM. Diabetes Care 18: 618-624
16. Levy D, Garrison RJ, Savane DD, Kannel WR, Castelli WP 1990 Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 322: 1561-1566
17. London GM, Marchais SJ, Safar MK et al 1990 Aortic and large artery compliance in end-stage renal failure. Kidney Int 37: 137-142
18. London GM, Guerin AP, Marchais SJ et al 1996 Cardiac and arterial interactions in end-stage renal disease. Kidney Int 50: 600-608
19. London GM, Drüeke TB 1997 Atherosclerosis and arterosclerosis in chronic renal failure. Kidney Int 51: 1678-1695
20. Luik AJ, Spek JJ, Charra B, van Bortel LMAB, Laurent G, Leunissen KML 1997 Arterial compliance in patients on long-treatment-time dialysis. Nephrol Dial Transplant 12: 2629-2632
21. Majors A, Ehrhart AL, Pezacka EH 1997 Homocysteine as a risk factor for vascular disease: Enhanced collagen production and accumulation by smooth muscle cells. Arterioscler Thromb Vasc Biol 17: 2074-2081
22. Malinow MR, Levenson J, Giral P et al 1995 Role of blood pressure, urid acid, and hemorheological parameters on plasma homocyst(e)ine concentration. Atherosclerosis 114: 175-183
23. McCully KS 1970 Importance of homocysteine-induced abnormalities of proteoglycan structure in arteriosclerosis. Am J Pathol 59: 181-193
24. Mourad JJ, Girerd X, Boutouyrie P, Laurent S, Safar M, London G 1997 Increased stiffness of radial artery wall material in end-stage renal disease. Hypertension 30: 1425-1430
25. Monstapha A, Naso A, Nahlawi M et al 1998 Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 97: 138-141
26. Nichols WW, O'Rourke MF 1998 McDonald's Blood Flow in Arteries. Arnold, London
27. Silberberg JS, Barre PE, Prichard SS, Sniderman AD 1989 Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36: 286-290
28. Tsai JC, Perrella MA, Yoshizumi M et al 1994 Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis. Proc Natl Acad Sci USA 91: 6369-6373
29. Woo KS, Chook P, Lolin YI et al 1997 Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 96: 2542-2544